Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis

doi:10.4254/wjh.v16.i8.1145

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (37)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-1)

Sum=34

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Aug 27, 2024 (publication date) through Aug 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Hepatol. Aug 27, 2024; 16(8): 1145-1155
Published online Aug 27, 2024. doi: 10.4254/wjh.v16.i8.1145

Full Size Figure Download Figure

Figure 3 Inverse-variance weighted–Mendelian randomization results before and after correcting for waist-to-hip ratio and type 2 diabetes using the multivariable Mendelian randomization framework. A: Blood cell counts associated liver enzyme; B: Blood cell counts associated liver enzyme. OR: Odds ratio; RBC: Red blood cell count; HGB: Haemoglobin concentration; HCT: Haematocrit; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transferase; AST: Aspartate aminotransferase; NAFLD: Nonalcoholic fatty liver diseases; T2D: Type 2 diabetes.

Citation: Hu B, Wan AH, Xiang XQ, Wei YH, Chen Y, Tang Z, Xu CD, Zheng ZW, Yang SL, Zhao K. Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis. World J Hepatol 2024; 16(8): 1145-1155
URL: https://www.wjgnet.com/1948-5182/full/v16/i8/1145.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i8.1145